×

Search

Search
News
News
Check category
/
/
Lunan Pharmaceutical Group New Era Pharmaceutical Co., Ltd. awarded Chutian Technology the honor of "Quality Supplier"

Lunan Pharmaceutical Group New Era Pharmaceutical Co., Ltd. awarded Chutian Technology the honor of "Quality Supplier"

  • Categories:News
  • Time of issue:2021-11-12 14:59
  • Views:

(Summary description)Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

Lunan Pharmaceutical Group New Era Pharmaceutical Co., Ltd. awarded Chutian Technology the honor of "Quality Supplier"

(Summary description)Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

  • Categories:News
  • Time of issue:2021-11-12 14:59
  • Views:
Information

Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

The sudden outbreak of the new crown epidemic in 2020 has had a huge impact on the world economy. "2021 is gradually entering the post-epidemic era. A new round of industrial transformation has already occurred. Various industries that have been disrupted in their development rhythm are actively embracing changes and promoting transformation." Zhang Lixing, deputy general manager of Southern Pharmaceutical Group and general manager of Shandong New Times Pharmaceutical Co., Ltd., said at the forum, “In the face of the current situation, how to seize the opportunity to achieve synergy? How to improve the sustainability of our own development in the post-epidemic era ? Our answer is to discuss together, build together, and share. The purpose of this forum is to deepen understanding, increase mutual trust, and expand cooperation."

Lunan Pharmaceutical Group has a development history of more than half a century, and has always adhered to the business tenet of "benefiting the society and creating a better life". According to Zhang Lixing, Lunan Pharmaceutical Group is developing well, chemical pharmaceuticals are advancing steadily, Chinese medicine industry is emerging, and biopharmaceuticals are beginning to emerge. The performance of the first half of 2021 increased by 25% compared with the same period last year. In 2021, the brand value reached 12.191 billion yuan, ranking among the top No. 5 in the pharmaceutical and health industry, the export volume in 2020 has exceeded 1 billion yuan, and it is making great strides towards internationalization. "I hope everyone will work together, cooperate and win-win, and step on the road of common development!"

Lunan Pharmaceutical Group is a comprehensive pharmaceutical group integrating the production, scientific research and sales of pharmaceuticals, chemical drugs, and biological products. It owns Lunan Houpe Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., and Shandong New Times Pharmaceutical Co., Ltd. , Lunan New Era Pharmaceutical Co., Ltd. and many other companies, ranked among the top 500 competitiveness of China's large enterprise groups, and top 500 Chinese private enterprises in manufacturing. They have been on the list of Shandong Province's top 100 taxpayers for many years, and have been listed in the 2019 China Pharmaceutical Industry. Ranked 22 on the top 100 list, Lunan Pharmaceutical's brand value will reach 12.191 billion yuan in 2021.

Zeng Fanyun, CEO of Chutian Technology, was invited to give a speech at the forum as the representative of Lunan Pharmaceutical Group’s strategic partners. He said, “Lunan Pharmaceuticals has been working with Chutian Technology for 19 years. In this long-term cooperation process, we are not simply demanding and The supply relationship has developed into a strategic partner moving towards the same goal. Chutian Technology deeply admires the Lunan Pharmaceutical Group in corporate culture, management innovation, technological innovation and other aspects, and has been deeply and positively affected. Learn from experience and absorb nutrition to promote self-improvement and development."

Lunan Pharmaceutical Group adheres to the business tenet of "benefiting society and creating a better life" and has established the corporate vision of "building a leading domestic and world-class comprehensive medical research and production base". Zeng Fanyun said in his speech at the forum, "This makes us deeply Admire. Chutian Technology shoulders the mission of letting the world's pharmaceutical industry plug in the wings of wisdom, and establishes the vision to develop into one of the world's leading pharmaceutical equipment companies, which fully reflects the depth of Chutian Technology and Lunan Pharmaceutical Group at the business level The agreement also fully embodies Chutian Technology's determination to assist the development of its partners."

"In terms of management innovation, Lunan Pharmaceutical Group can be described as a star mentor of Chutian Technology, because in the long-term cooperation, we have deeply felt Lunan Pharmaceutical Group’s rigorous management attitude, advanced management concepts and scientific management methods, and also profoundly Feeling the unity and win-win situation of Lunan Pharmaceutical Group, Chutian Technology has always learned from Lunan Pharmaceutical Group." Zeng Fanyun said, "In terms of technological innovation, in the long-term sincere cooperation process, we have been in many fields. A deep cooperative relationship has been formed, and Chutian Technology has benefited a lot from it."

Zeng Fanyun said that Chutian Technology is very grateful for the high trust and strong support given by Lunan Pharmaceutical Group, as well as the continuous improvement of requirements. Self-iteration, continuous improvement, innovation and excellence in plan design, production quality, delivery efficiency and other aspects. Demanding customers and thoughtful partners are our guides in innovation. Chutian Technology will invest more resources to follow The development pace of Lunan Pharmaceutical Group has created greater value for Lunan Pharmaceutical Group."

 

Hot News

11-12
2021
Zhifeilong Kema awarded Chutian Huatong the honor of "Excellent Technical Team" and "Excellent Supplier"

Li Wanjun, chairman of Anhui Zhifeilongkoma Biopharmaceutical Co., Ltd., Jiang Pan, deputy general manager, and Wei Pingzhi, project manager, visited Chutian Huatong on August 6th and served as the R&D center of Chutian Huatong Zhifeilongkoma Industrial Park The executive team of the project and the New Crown Vaccine Project awarded Chutian Huatong the honorary titles of "Excellent Technical Team" and "Excellent Supplier", and awarded Chutian Huatong employees Jiang Haiyang and Cai Fuqiang "Excellent Project Manager" and "Excellent Construction Manager" "Honorary title," at the same time as a gift to Chutian Huatong Chairman Yang Wenlu and employees Jiang Haiyang and Cai Fuqiang "Zhifei Biological 100 million doses" commemorative silver coins.

11-12
2021
All employees have completed the new crown vaccination, and Chutian Technology's production is running at full capacity

Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

11-12
2021
Chutian Technology's first season ingenuity plan was officially launched. Chairman Tang Yue gave a speech at the opening ceremony

Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

11-12
2021
Lunan Pharmaceutical Group New Era Pharmaceutical Co., Ltd. awarded Chutian Technology the honor of "Quality Supplier"

Shandong New Times Pharmaceutical Co., Ltd., a subsidiary of Lunan Pharmaceutical Group, held the first high-level forum for high-quality equipment suppliers in Linyi City, Shandong Province on July 20. Chutian Technology has made a leap in the course of cooperation with Lunan Pharmaceutical Group. Zeng Fanyun, a strategic partner for nearly 20 years, was invited to participate in the forum and accepted the honor of "Quality Supplier" awarded by New Era Pharmaceutical on behalf of the company.

11-12
2021
Chen Fei, Vice Governor of Hunan Province, and his team investigated Chutian Technology

Chutian Technology's 2021 semi-annual report was released on August 27. Many indicators such as revenue and net profit have risen sharply. In the first half of the year, operating income was 2.391 billion yuan, a year-on-year increase of 72.75%; net profit attributable to shareholders of listed companies was 236 million Yuan, a year-on-year increase of 1321.22%. Among the many product sectors that support business performance, inspection and packaging solutions and stand-alone business are very eye-catching, with revenue reaching 830 million yuan, an increase of 135.42% year-on-year, while the bioengineering solutions and stand-alone business sectors are developing rapidly, with revenue increasing year-on-year 255.41%. R&D investment continued to rise steadily, reaching nearly 200 million yuan, a year-on-year increase of 65.65%. Although overseas markets are affected by the uncertainty of the new crown epidemic, Chutian Technology has also performed well in several overseas regions in the first half of 2021. For example, revenue in Europe increased by 11.27% and revenue in America increased by 74.67%.

11-12
2021
Chutian Technology released its 2021 semi-annual report, and its overall revenue increased by 72.75%, and its bioengineering business developed rapidly

楚天科技2021年半年度报告8月27日发布,营收、净利润等多项指标均大幅上扬,上半年营业收入23.91亿元,同比增长72.75%;归属于上市公司股东的净利润2.36亿元,同比增长1321.22%。在支撑起经营业绩的众多产品板块中,检测包装解决方案及单机业务十分亮眼,营收达到8.3亿元,同比增长135.42%,生物工程解决方案及单机业务板块则发展迅猛,营收同比增长255.41%。研发投入继续稳步抬升,近2亿元,同比增长65.65%。海外市场虽然受到新冠疫情的不确定性影响,但楚天科技2021年上半年在若干海外地区也有不错表现,比如欧洲地区营收同增11.27%、美洲地区营收同增74.67%。

×
We will get in touch with you in time
Truking Ingenuity Biotechnology(ChangSha) Co.Ltd


Tel:0731-87053648 
E-mail:zls@uitbp.com
Add:Truking Technology Industrial Park,Ningxiang National Economic and Technological Development Zone

Copyright 2020 Truking Ingenuity Biotechnology(ChangSha) Co.Ltd  备案号:湘ICP备2022002279号-1   300.cn